Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of Fisetin supplementation on nutritional and inflammatory status of colorectal cancer patients receiving adjuvant chemotherapy in association with TYMS and MTHFR genes polymorphism

ABSTRACT: Intervention 1: Daily supplementation of one 100 mg capsule with food (starting from a week before chemotherapy until the end of second chemotherapy cycle ( a total of 7 weeks). Intervention 2: Daily supplementation of one placebo capsule with food (starting form a week before chemotherapy until the end of second chemotherapy cycle ( a total of 7 weeks).;Placebo;Daily supplementation of one 100 mg capsule with food (starting from a week before chemotherapy until the end of second chemotherapy cycle ( a total of 7 weeks);Daily supplementation of one placebo capsule with food (starting form a week before chemotherapy until the end of second chemotherapy cycle ( a total of 7 weeks) Primary outcome(s): Serum levels of Matrix Metalloproteinase-7 , 9 (MMP-7,9). Timepoint: Before and after the intervention (7 weeks). Method of measurement: ElISA. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive.

DISEASE(S): Colorectal Cancer,Neoplasms,digestive Organs

PROVIDER: 2487787 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Real-time quantitative PCR analysis of human total blood tissue from athletes or sedentary controls

Project description:Thirteen elite handball athletes and 13 sedentary controls. Three timepoints were established: T0 (baseline conditions); T8 (after 8 weeks of supplementation); and T16 (after 8 weeks in the absence of supplementation). The dietary intervention consisted of the oral administration of one daily multivitamin/mineral complex capsule (Multicentrum® Pfizer, Barcelona, Spain) before exercise during the controlled dietary intervention period. Multivitamin/mineral complex intervention adherence/compliance was defined as the percentage of all of the supplement capsules ingested throughout the study period. The expressions of a total 112 of genes were evaluated by RT-qPCR analysis with the QuantStudioTM 12K Flex Real-Time PCR System. 78 genes were finally analized.

2019-11-23 | GSE140874 | GEO

Effects of conjugated linoleic acid supplemntation on nutritional status, matrix metalloproteinases enzymes , inflammatory and oxidative factors in colorectal cancer patients undergoing chemoradiotherapy

Project description:Intervention 1: In supplemented group,patients will consume four 1000 mg capsules daily (providing 3 gr CLA ) for 6 weeks .Patients are instructed to take once at each of 3 mealtimes and once before bedtime. The supplementation begins 1 week before starting radiotherapy. Intervention 2: In placebo group,patients will consume four placebo capsules daily for 6 weeks . Patients are instructed to take once at each of 3 mealtimes and once before bedtime. The intervention begins 1 week before starting radiotherapy.;Prevention;Placebo;In supplemented group,patients will consume four 1000 mg capsules daily (providing 3 gr CLA ) for 6 weeks .Patients are instructed to take once at each of 3 mealtimes and once before bedtime. The supplementation begins 1 week before starting radiotherapy.;In placebo group,patients will consume four placebo capsules daily for 6 weeks . Patients are instructed to take once at each of 3 mealtimes and once before bedtime. The intervention begins 1 week before starting radiotherapy. Primary outcome(s): Serum conjugated linoleic acid. Timepoint: Before radiotherpay and at the end of intervention(6 weeks). Method of measurement: Gas Chromatography.;Inflammatory factors(TNF-a, IL-1, IL-6, hs-CRP). Timepoint: Before radiotherpay and at the end of intervention(6 weeks). Method of measurement: Elisa kit, hs-CRP: kit immunoturbidimetry. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention.

| 2476095 | ecrin-mdr-crc

Analysis of 20-HETE supplementation in calorically restricted C57Bl6 mice

Project description:Proteomic dataset of 15 murine kidneys of 14-week-old male C57Bl6 mice. Mice were divided into 3 treatment groups four weeks prior to nephrectomy and 5 mice had ad libitum access to food and water, while another 10 mice received 30% food restriction. Calorically restricted mice either received intraperitoneal supplementation of 20-HETE or vehicle (EtOH in sodiumchloride 0.9%) for 8 days on a daily basis prior to nephrectomy. Ad libitum fed mice received vehicle injections for 8 days on a daily basis prior to nephrectomy.

2022-06-17 | PXD031604 | Pride

Effect of 20-Hete and dietary restriction on murine kidneys

Project description:Transcriptomic dataset of 15 murine kidneys of 14-week-old male C57Bl6 mice. Mice were divided into 3 treatment groups four weeks prior to nephrectomy and 5 mice had ad libitum (AL) access to food and water, while another 10 mice received 30% food restriction (CR). Calorically restricted mice either received intraperitoneal supplementation of 20-HETE (HETE) or vehicle (Veh, EtOH in sodiumchloride 0.9%) for 8 days on a daily basis prior to nephrectomy. Ad libitum fed mice received vehicle injections for 8 days on a daily basis prior to nephrectomy.

2022-05-10 | E-MTAB-11428 | biostudies-arrayexpress

NUTRITIONAL OPTIMISATION WITH SPECIFIC NUTRIENTS IN COLORECTAL CANCER PATIENTS RECEIVING CHEMOTHERAPY; A CASE CONTROL STUDY, RANDOMIZED CONTROLLED TRIAL

Project description:Intervention 1: Fish oil /intervention. 1200mg (providing omega-3 420 mg EPA and 280 mg DHA) 5 times daily for 8 weeks after starting chemotherapy. Intervention 2: Probiotics/ intervention. 3 gr Granule contains the following probiotic strains: L.acidophilus, L. lactis, L. casei subsp, L. longum, L. bifidum, L. infantis twice a day for 4 weeks after starting chemotherapy. Intervention 3: Sunflower oil /control 1200mg 5 times daily for 8 weeks after starting chemotherapy. Intervention 4: Lactose / control 3 gr Granule contains: Lactose, Maltodextrin, Citric Acid, Ascorbic Acid, Skim Milk Powder, and Sugar twice a day for 4 weeks after starting chemotherapy.;Treatment - Drugs;Treatment - Drugs;Placebo;Placebo;Fish oil /intervention. 1200mg (providing omega-3 420 mg EPA and 280 mg DHA) 5 times daily for 8 weeks after starting chemotherapy;Probiotics/ intervention. 3 gr Granule contains the following probiotic strains: L.acidophilus, L. lactis, L. casei subsp, L. longum, L. bifidum, L. infantis twice a day for 4 weeks after starting chemotherapy;Sunflower oil /control 1200mg 5 times daily for 8 weeks after starting chemotherapy;Lactose / control 3 gr Granule contains: Lactose, Maltodextrin, Citric Acid, Ascorbic Acid, Skim Milk Powder, and Sugar twice a day for 4 weeks after starting chemotherapy Primary outcome(s): Quality of life. Timepoint: Before starting chemotherapy and supplementationa nd after completion of supplementation and chemotherapy. Method of measurement: EORTC QLQ C-30. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention.

| 2476898 | ecrin-mdr-crc

RNA sequencing of sheep infraspinatus muscle after tendon release and repair under concomitant nandrolone administration

Project description:Transcripts were measured in infraspinatus muscle before (PRE) and after 16 weeks of tendon release (TR) and 6 weeks of subsequent repair (END) in the operated and contralateral (END-CC) muscle. A group of animals received intramuscular injections of nandrolone starting with the surgery (N22W). In another group injection of nandrolone was started at the time of tendon repair (N6W). The CONTROL group received no nandrolone.

2016-12-31 | GSE80374 | GEO

First ruxolitinib treatment of human alopecia areata patients

Project description:Two patients with alopecia areata were treated with systemic ruxolitinib. Skin biopsies were taken before starting treatment and 12 weeks after starting treatment. We used microarrays to assess changes in gene expression of affected skin before and after starting treatment

2014-08-17 | GSE58573 | GEO

scAT gene expression from women with PCOS following LC n-3 PUFA or placebo supplementation

Project description:Gene expresion profiles from the scAT following 6 week LC n-3 PUFA and 6 week placebo supplementation were compared Women with PCOS were supplemented with 4g n-3 PUFA (containing 1.8g EPA and DHA) daily for 6 weeks and changes in subcutaneous adipose tissue gene expression was compared with 6 week placebo supplementation.

2014-01-03 | GSE43266 | GEO

Tuina reverses capsule fibrosis in Frozen Shoulder as indicated via protemocis

Project description:Frozen shoulder (FS) is a common disorder often treated with Tuina, but the mechanisms involved remain unclear. We employed proteomics to investigate the mechanisms associated with the treatment of capsule fibrosis in FS rats. We used a method composed of three weeks of cast immobilization to establish a model of FS. We then administered Tuina once daily for 14 days, identified differentially expressed proteins (DEPs) using proteomics. Then we used bioinformatics methods to study the mechanism of tuina therapy

2024-01-09 | PXD047467 | Pride

Tuina reverses capsule fibrosis in Frozen Shoulder as indicated via phosphoproteomics

Project description:Frozen shoulder (FS) is a common disorder often treated with Tuina, but the mechanisms involved remain unclear. We employed proteomics to investigate the mechanisms associated with the treatment of capsule fibrosis in FS rats. We used a method composed of three weeks of cast immobilization to establish a model of FS. We then administered Tuina once daily for 14 days, identified differentially expressed proteins (DEPs) using phosphoproteomics. Then we used bioinformatics methods to study the mechanism of tuina therapy

2024-01-09 | PXD047468 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data